Review Article
Impact of National Economy and Policies on End-Stage Kidney Care in South Asia and Southeast Asia
Table 4
Country wise dropout rate & growth projections.
| Countries | Total dropout rate at 1 year (%) | Dropout rate | Percentage growth projections over the next five years (2023) | Percentage distribution of total dropouts | Due to death (%) | Due to KT | Due to finances | ESKD growth | HD growth | PD growth |
| Singapore | 11.96 | 99.5 | 0.5 | 0 | >20 | >20 | 10 to 20 | Brunei | 15.3 | 98 | 2 | 0 | >20 | >20 | >20 | Hong Kong | DNA | DNA | DNA | DNA | 10 to 20 | 10 to 20 | 10 to 20 | Taiwan | 12 | 98.3 | 1.7 | 0 | <10 | <10 | <10 | Malaysia | 12 | 87 | 12 | 1 | >20 | 10 to 20 | >20 | Thailand | 10 | 85 | 12 | 3 | 10 to 20 | 10 to 20 | 10 to 20 | Sri Lanka | 65 | 15.3 | 46.3 | 38.4 | >20 | >20 | 10 to 20 | Indonesia | 33.5 | 95.5 | 4.5 | 0 | 10 to 20 | DNA | DNA | Philippines | DNA | DNA | DNA | DNA | 10 to 20 | <10 | <10 | India | 67 | 43.2 | 37.3 | 19.4 | 10 to 20 | >20 | 10 to 20 | Vietnam | 15 | DNA | DNA | DNA | 10 to 20 | <10 | <10 | Myanmar | DNA | DNA | DNA | DNA | 10 to 20 | 10 to 20 | <10 | Pakistan | 90 | 45 | 5 | 50 | 10 to 20 | <10 | No growth | Bangladesh | 50 | 20 | 10 | 70 | <10 | 10 to 20 | 10 to 20 | Nepal | DNA | DNA | DNA | DNA | >20 | >20 | >20 |
|
|
ESKD, end-stage kidney disease; PD, peritoneal dialysis; HD, hemodialysis; KT, kidney transplant; CS, conservative; DNA, data not available.
|